A new article published by JAMA Oncology compares outcomes for combined mammography and magnetic resonance imaging (MRI) or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.

The Department of Human Oncology at the University of Wisconsin-Madison has entered into an agreement with RaySearch to pioneer the RayCare oncology information system (OIS). The new system will be used in the department’s multidisciplinary approach to cancer care and its focus on cutting-edge techniques.

In an article published in the June 2017 issue of The Journal of Nuclear Medicine, researchers assert that exposure to medical imaging radiation not only doesn’t increase an adult person’s risk of getting cancer, it doesn’t increase a child’s risk. According to the authors, the long-held belief that even low doses of radiation, such as those received in diagnostic imaging, increase cancer risk is based on an inaccurate, 70-year-old hypothesis and leads to unnecessary fear and misdiagnoses.

Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France, is providing advanced radiation treatments to cancer patients using the smart Radixact Treatment Delivery System, the first to be installed in France. The IUCT Oncopole began treating patients in January with this new system, designed to deliver image-guided intensity-modulated radiation therapy (IG-IMRT), an extremely precise form of radiation therapy.

The Henry Ford Cancer Institute is the first in Michigan – and first in the world – to offer patients advanced radiation therapy with the ViewRay MRIdian Linac system. The system uses a U.S. Food and Drug Administration (FDA)-approved real-time magnetic resonance imaging (MRI) and linear accelerator delivery for more precise and accurate radiation treatment.

Fujifilm Medical Systems U.S.A. Inc. presented its comprehensive Synapse Enterprise Imaging portfolio at the 2017 Annual Meeting of the Society for Imaging Informatics in Medicine (SIIM), held June 1-3 in Pittsburgh. The annual meeting featured advancements in medical imaging, cutting-edge scientific research and enterprise imaging thought leaders.

The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Vida 3 Tesla (3T) magnetic resonance imaging (MRI) scanner from Siemens Healthineers, which features new BioMatrix technology that addresses inherent anatomical and physiological differences among patients, as well as user variability.